[시장보고서]세계의 호흡기내 치료 기기 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 기기별, 최종사용자별, 전문의별, 지역별, 경쟁별(2020-2030년)

세계의 호흡기내 치료 기기 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 기기별, 최종사용자별, 전문의별, 지역별, 경쟁별(2020-2030년)

Respiratory Endotherapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Devices, By End User, By Specialist, By Region & Competition, 2020-2030F

상품코드 : 1697982

리서치사 : TechSci Research

발행일 : 2025년 03월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,531,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,982,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,611,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

호흡기내 치료 기기 세계 시장 규모는 2024년 14억 5,000만 달러에 달했으며, 2030년까지 예측 기간 동안 연평균 5.33%의 강력한 성장을 보일 것으로 예상됩니다.

코로나19 팬데믹은 초기에 호흡기 시장에 큰 영향을 미쳤습니다. 그러나 정부의 이니셔티브와 정책, 그리고 부족을 극복하기 위한 기업의 전략적 개척의 결과로 호흡기 기기 시장은 크게 성장했습니다. 예를 들어, 2021년 5월, 세계기금은 인도의 코로나19 위기 대응을 지원하기 위해 7,500만 달러의 신속한 자금 지원을 승인했습니다. 이 새로운 자금은 인도가 산소 농축 장치와 압력 스윙 흡착(PSA) 산소 플랜트를 구입하여 인도의 중기 의료용 산소 수요를 충족시키는 데 도움이되었습니다. 따라서 코로나19 환자가 급증하면서 호흡기 기기에 대한 수요가 증가하여 시장 성장에 박차를 가하고 있습니다. 그러나 코로나19의 이용 사례가 감소하고 팬데믹으로 인해 호흡기 기기 사용이 가속화됨에 따라 조사 대상 시장은 조사 기간 동안 안정적인 성장을 보일 것으로 예상됩니다. 예를 들어, WHO에 따르면 폐암은 전 세계 암 사망 원인 중 1위이며, 그 중 85%가 흡연으로 인한 것입니다. 고위험군의 조기 검진은 생존율을 향상시키고, 담배 규제 및 환경적 위험 요인 감소와 같은 1차 예방 대책은 발병률을 낮추고 생명을 구하는 데 매우 중요합니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	14억 5,000만 달러
시장 규모 : 2030년	19억 6,000만 달러
CAGR : 2025-2030년	5.33%
급성장 부문	진단 기기
최대 시장	북미

시장 성장 촉진요인

호흡기 질환 유병률 증가

주요 시장 이슈

호흡기 내 치료 기기의 높은 비용

주요 시장 동향

저침습 기술의 발전

시장 규모와 예측
- 금액별
시장 점유율과 예측
- 기기별(진단 기기, 치료 기기)
- 최종사용자별(말초혈관 인터벤션, 혈관내 인터벤션, 심장, 중재적 방사선학, 정맥, 기타)
- 전문의별(병원, 진단센터, 외래수술센터(ASC))
- 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
- 기업별(2024년)
시장 맵
디바이스별
최종사용자별
전문의별
지역별

제6장 북미의 호흡기내 치료 기기 시장 전망

시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 미국
- 캐나다
- 멕시코

제7장 유럽의 호흡기내 치료 기기 시장 전망

시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 프랑스
- 프랑스
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 호흡기내 치료 기기 시장 전망

시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 호흡기내 치료 기기 시장 전망

시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 호흡기내 치료 기기 시장 전망

시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
인수합병(M&A)
제품 출시

제13장 세계의 호흡기내 치료 기기 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협

제15장 경쟁 구도

Fujifilm Holdings Corporation.
Medtronic plc.
Johnson & Johnson.
Smith & Nephew Plc.
Stryker corporation.
Olympus corporation.
Hoya corporation.
Steris Healthcare.
Conmed corporation.
Boston Scientific corporation.

제16장 전략적 제안

제17장 리서치사에 대해 & 면책사항

LSH

영문 목차

영문목차

Global Respiratory Endotherapy Devices Market was valued at USD 1.45 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2030. The COVID-19 pandemic had a substantial impact on the respiratory devices market initially. However, the respiratory device market grew significantly as a result of government initiatives and policies, as well as the company's strategic developments to overcome the shortfall. For instance, in May 2021, the Global Fund approved USD 75 million in fast-track funding to support India's response to the COVID-19 crisis. This new funding helped India purchase oxygen concentrators and pressure swing adsorption (PSA) oxygen plants to help meet the country's medium-term medical oxygen needs. Hence, due to the surge in COVID-19 cases, the demand for respiratory devices increased, thereby fueling the growth of the market. However, as COVID-19 cases declined and the pandemic accelerated the use of respiratory devices, the studied market is now expected to project stable growth over the studied period. For instance, according to WHO, lung cancer is the leading cause of cancer deaths globally, with smoking responsible for 85% of cases. Early screening of high-risk individuals can improve survival rates, while primary prevention measures, such as tobacco control and reducing environmental risk factors, are crucial in lowering incidence and saving lives.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.45 Billion
Market Size 2030	USD 1.96 Billion
CAGR 2025-2030	5.33%
Fastest Growing Segment	Diagnostic Devices
Largest Market	North America

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The escalating incidence of respiratory disorders worldwide is poised to propel the expansion of the Global Respiratory Endotherapy Devices Market. The rising prevalence of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections is fostering an increased demand for advanced therapeutic interventions. Respiratory endotherapy devices play a pivotal role in the management of these disorders, offering minimally invasive and targeted treatments. For instance, According to the U.S. Centers for Disease Control and Prevention (CDC), smoking is responsible for approximately 8 out of 10 COPD-related deaths. Additionally, increasing levels of indoor and outdoor air pollution, along with exposure to dust and harmful chemicals, are significant contributors to the rising prevalence of COPD. As the global population ages and environmental factors contribute to respiratory health challenges, the need for effective and efficient endotherapy solutions is becoming more pronounced. The market is witnessing a surge in technological innovations, including bronchoscopes, tracheoscopes, and other endoscopic devices, which enhance diagnostic accuracy and treatment precision. Healthcare providers are increasingly adopting these devices to address respiratory issues, contributing to the overall market growth. The growing awareness among patients and healthcare professionals regarding the benefits of endotherapy, such as reduced recovery times and improved patient outcomes, is driving the uptake of these devices. In conclusion, the escalating burden of respiratory disorders, coupled with technological advancements in endotherapy, is anticipated to foster significant growth in the Global Respiratory Endotherapy Devices Market in the coming years.

Key Market Challenges

High Cost of Respiratory Endotherapy Devices

The high cost associated with respiratory endotherapy devices is anticipated to pose a significant impediment to the growth of the Global Respiratory Endotherapy Devices Market. The substantial financial investment required for acquiring these sophisticated medical devices can act as a deterrent for healthcare institutions, particularly in regions with constrained healthcare budgets. The intricate technology and specialized materials involved in manufacturing respiratory endotherapy devices contribute to their elevated price point, limiting accessibility for certain healthcare facilities and hindering widespread adoption. The financial burden on patients seeking respiratory treatments may curb patient acceptance and usage. High device costs often translate to increased procedural expenses, potentially affecting reimbursement policies and posing challenges for both healthcare providers and patients. Market players need to address these cost-related concerns through strategic initiatives such as research and development aimed at cost reduction, exploring partnerships for shared investments, and advocating for favorable reimbursement policies. Mitigating the economic barriers associated with respiratory endotherapy devices is crucial for fostering market growth and ensuring broader access to these advanced medical solutions in the evolving landscape of respiratory healthcare.

Key Market Trends

Advancements in Minimally Invasive Technologies

The growth trajectory of the Global Respiratory Endotherapy Devices Market is poised to be significantly steered by continual advancements in minimally invasive technologies. As medical science evolves, there is a paradigm shift towards procedures that offer reduced patient trauma, shorter recovery times, and enhanced precision. Respiratory endotherapy devices are at the forefront of this transformative trend, providing cutting-edge solutions for the diagnosis and treatment of respiratory disorders with minimal invasiveness. Innovations in endoscopic technologies, including the development of high-definition imaging and advanced navigation systems, empower healthcare practitioners to conduct intricate respiratory procedures with unprecedented clarity and accuracy. The integration of robotics and artificial intelligence further augments the capabilities of respiratory endotherapy devices, enabling more precise interventions and personalized treatment strategies. This technological evolution not only enhances the efficacy of respiratory procedures but also contributes to increased patient acceptance. As the global healthcare landscape embraces these advancements, the demand for state-of-the-art respiratory endotherapy devices is expected to rise, driving market growth. In essence, the continual refinement of minimally invasive technologies is a pivotal catalyst propelling the expansion of the Global Respiratory Endotherapy Devices Market, shaping the future of respiratory healthcare.

Key Market Players

Fujifilm Holdings Corporation.
Medtronic plc.
Johnson & Johnson.
Smith & Nephew Plc.
Stryker corporation.
Olympus corporation.
Hoya corporation.
Steris Healthcare.
Conmed corporation.
Boston Scientific corporation.

Report Scope:

In this report, the Global Respiratory Endotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Endotherapy Devices Market, By Devices:

Diagnostic Devices
Therapeutic Devices

Respiratory Endotherapy Devices Market, By End User:

Peripheral Vascular Intervention
Endovascular Interventions
Cardiac
Interventional Radiology
Venous
Others

Respiratory Endotherapy Devices Market, By Specialist:

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers

Respiratory Endotherapy Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Endotherapy Devices Market.

Available Customizations:

Global Respiratory Endotherapy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Endotherapy Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 5.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 5.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 5.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 5.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 5.2.5. By Company (2024)
5.3. Market Map
5.3.1 By Devices
5.3.2 By End User
5.3.3 By Specialist
5.3.4 By Region

6. North America Respiratory Endotherapy Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 6.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 6.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 6.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 6.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Respiratory Endotherapy Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Devices
    - 6.3.1.2.2. By End User
    - 6.3.1.2.3. By Specialist
- 6.3.2. Canada Respiratory Endotherapy Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Devices
    - 6.3.2.2.2. By End User
    - 6.3.2.2.3. By Specialist
- 6.3.3. Mexico Respiratory Endotherapy Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Devices
    - 6.3.3.2.2. By End User
    - 6.3.3.2.3. By Specialist

7. Europe Respiratory Endotherapy Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 7.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 7.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 7.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 7.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Respiratory Endotherapy Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Devices
    - 7.3.1.2.2. By End User
    - 7.3.1.2.3. By Specialist
- 7.3.2. Germany Respiratory Endotherapy Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Devices
    - 7.3.2.2.2. By End User
    - 7.3.2.2.3. By Specialist
- 7.3.3. United Kingdom Respiratory Endotherapy Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Devices
    - 7.3.3.2.2. By End User
    - 7.3.3.2.3. By Specialist
- 7.3.4. Italy Respiratory Endotherapy Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Devices
    - 7.3.4.2.2. By End User
    - 7.3.4.2.3. By Specialist
- 7.3.5. Spain Respiratory Endotherapy Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Devices
    - 7.3.5.2.2. By End User
    - 7.3.5.2.3. By Specialist

8. Asia-Pacific Respiratory Endotherapy Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 8.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 8.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 8.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 8.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Respiratory Endotherapy Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Devices
    - 8.3.1.2.2. By End User
    - 8.3.1.2.3. By Specialist
- 8.3.2. India Respiratory Endotherapy Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Devices
    - 8.3.2.2.2. By End User
    - 8.3.2.2.3. By Specialist
- 8.3.3. Japan Respiratory Endotherapy Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Devices
    - 8.3.3.2.2. By End User
    - 8.3.3.2.3. By Specialist
- 8.3.4. South Korea Respiratory Endotherapy Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Devices
    - 8.3.4.2.2. By End User
    - 8.3.4.2.3. By Specialist
- 8.3.5. Australia Respiratory Endotherapy Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Devices
    - 8.3.5.2.2. By End User
    - 8.3.5.2.3. By Specialist

9. South America Respiratory Endotherapy Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 9.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 9.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 9.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 9.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Respiratory Endotherapy Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Devices
    - 9.3.1.2.2. By End User
    - 9.3.1.2.3. By Specialist
- 9.3.2. Argentina Respiratory Endotherapy Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Devices
    - 9.3.2.2.2. By End User
    - 9.3.2.2.3. By Specialist
- 9.3.3. Colombia Respiratory Endotherapy Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Devices
    - 9.3.3.2.2. By End User
    - 9.3.3.2.3. By Specialist

10. Middle East and Africa Respiratory Endotherapy Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Devices (Diagnostic Devices, Therapeutic Devices)
  - 10.2.1.1. By Diagnostic Devices (Trans Bronchial Aspiration, Biopsy forceps, Cytology Brushes, Others)
  - 10.2.1.2. By Therapeutic Devices (Bronchoscope, Bronchial Thermoplasty Systems, Pulmonary Balloon Dilation Catheter, Stents, Others)
- 10.2.2. By End User (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional Radiology, Venous, Others)
- 10.2.3. By Specialist (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Respiratory Endotherapy Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Devices
    - 10.3.1.2.2. By End User
    - 10.3.1.2.3. By Specialist
- 10.3.2. Saudi Arabia Respiratory Endotherapy Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Devices
    - 10.3.2.2.2. By End User
    - 10.3.2.2.3. By Specialist
- 10.3.3. UAE Respiratory Endotherapy Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Devices
    - 10.3.3.2.2. By End User
    - 10.3.3.2.3. By Specialist

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Respiratory Endotherapy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Fujifilm Holdings Corporation.
- 15.1.1. Business Overview
- 15.1.2. Product Offerings
- 15.1.3. Recent Developments
- 15.1.4. Financials (As Reported)
- 15.1.5. Key Personnel
- 15.1.6. SWOT Analysis
15.2. Medtronic plc.
15.3. Johnson & Johnson.
15.4. Smith & Nephew Plc.
15.5. Stryker corporation.
15.6. Olympus corporation.
15.7. Hoya corporation.
15.8. Steris Healthcare.
15.9. Conmed corporation.
15.10. Boston Scientific corporation.